Platelet flux in trauma-associated venous thromboembolism: A secondary analysis of the Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) studies
- PMID: 40107968
- PMCID: PMC12097933
- DOI: 10.1097/TA.0000000000004592
Platelet flux in trauma-associated venous thromboembolism: A secondary analysis of the Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) studies
Abstract
Background: Venous thromboembolism (VTE) after traumatic injury is morbid. Evaluating changes in platelets in injured patients who develop VTE could identify platelet-based strategies for management of thrombotic complications after injury.
Methods: In a prospectively designed secondary analysis of a multicenter cohort study conducted by the Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT1) study group, injured patients aged 18 to 40 years admitted for a minimum of 48 hours with at least one risk factor for VTE were evaluated. A subset of CLOTT1 patients had platelet aggregometry and thromboelastography performed to examine platelet function (CLOTT2). Patients who developed VTE were compared with those who did not.
Results: Of 7,805 patients from CLOTT1 (mean [SD] age, 29.1 [6.4] years; 1,987 [25.5%] female), 425 (5.4%) developed VTE. Platelet count was lower at each time point for patients with VTE (admission: 242 [234-251] vs. 254 [252-256], p < 0.01; hospital day 1: 157 [150-164] vs. 197 [195-198], p < 0.01; all counts ×10 9 /L). An initial 10-point reduction in platelet count was associated with development of VTE (odds ratio, 1.32 [1.13-1.53]; p < 0.01) controlling for shock, injury severity, coagulopathy, sex, and product transfusion. When evaluating 129 CLOTT2 patients, velocity of platelet aggregation was higher on admission in the VTE group (18.5 vs. 12.8 aggregation units/min; p < 0.01) in response to adenosine diphosphate stimulation. In response to thrombin stimulation, velocity of platelet aggregation was higher at 48 hours (34.4 vs. 12.3 aggregation units/min; p < 0.01), and overall aggregation was higher in the VTE group at 72 hours (area under the curve, 173.2 vs. 129.6; p < 0.01). Thromboelastography results were not different between groups.
Conclusion: This study identified an association of early reduction in platelet count with the development of VTE in injured patients at risk for VTE. P2Y 1/2 and protease-activated receptor 1 receptor stimulation changes in platelet aggregation responses are altered in VTE patients. Interrogating platelet count and functional responses may be beneficial in evaluating thrombotic complications after injury.
Level of evidence: Diagnostic Test/Criteria; Level III.
Keywords: Venous thromboembolism; platelet function; thromboelastography.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest: Author Disclosure forms have been supplied and are provided as Supplemental Digital Content (
Similar articles
-
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Nov 08;11:CD010837. doi: 10.1002/14651858.CD010837.pub4. PMID: 28832905 Free PMC article. Updated.
-
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5. Cochrane Database Syst Rev. 2021. PMID: 34597414 Free PMC article.
-
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3. Cochrane Database Syst Rev. 2018. PMID: 29687454 Free PMC article.
-
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2. Cochrane Database Syst Rev. 2022. PMID: 36413425 Free PMC article.
-
High Risk of Venous Thromboembolism With Aspirin Prophylaxis After THA for High-riding Developmental Dysplasia of the Hip: A Retrospective, Comparative Study.Clin Orthop Relat Res. 2025 Jun 9. doi: 10.1097/CORR.0000000000003482. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 40536765
References
-
- Britt LD, Zolfaghari D, Kennedy E, Pagel KJ, Minghini A. Incidence and prophylaxis of deep vein thrombosis in a high risk trauma population. Am J Surg [Internet]. 1996;172(1):13–14 Available at: https://www.sciencedirect.com/science/article/pii/S0002961096000797. Accessed March 5, 2025. - PubMed
-
- Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth [Internet]. 2010;105(5):596–602 Available at: https://www.sciencedirect.com/science/article/pii/S0007091217334372. Accessed March 5, 2025. - PMC - PubMed
-
- Roger FB. Venous thromboembolism in trauma patients: a review. Surgery [Internet]. 2001;130(1):1–12 Available at: https://www.sciencedirect.com/science/article/pii/S0039606001979176. Accessed March 5, 2025. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials